Mammalian multipotent neural stem cells and compositions,...

Details Mammalian multipotent neural stem cells and compositions,... Mammalian multipotent neural stem cells and compositions,...

2003-01-14

2009-11-17

Gamett, Daniel C (Department: 1647)

Drug, bio-affecting and body treating compositions

Whole live micro-organism, cell, or virus containing

C435S377000, C435S368000, C435S372000, C435S373000, C435S366000, C435S325000, C424S093700

Reexamination Certificate

active

07618621

ABSTRACT:
This invention relates to novel mammalian multipotent neural stem cells (MNSCs), compositions thereof, and methods of preparing and administering the cells to diseased, aged or damaged tissue such that the cells properly migrate and differentiate and a neurological or corporal deficit is improved or remedied as a result.

REFERENCES:
patent: 4959368 (1990-09-01), Awaya
patent: 5104650 (1992-04-01), Ralph et al.
patent: 5411883 (1995-05-01), Boss et al.
patent: 5589376 (1996-12-01), Anderson et al.
patent: 5750376 (1998-05-01), Weiss et al.
patent: 5753506 (1998-05-01), Johe
patent: 5766948 (1998-06-01), Gage et al.
patent: 5851932 (1998-12-01), Weiss et al.
patent: 5925567 (1999-07-01), Kraus et al.
patent: 5968829 (1999-10-01), Carpenter
patent: 5976523 (1999-11-01), Awaya et al.
patent: 5980885 (1999-11-01), Weiss et al.
patent: 6013521 (2000-01-01), Gage et al.
patent: 6020197 (2000-02-01), Gage et al.
patent: 6040180 (2000-03-01), Johe
patent: 6090624 (2000-07-01), Greenwood et al.
patent: 6117675 (2000-09-01), Van der Kooy et al.
patent: 6254865 (2001-07-01), Freed et al.
patent: 6284245 (2001-09-01), Edge
patent: 6306575 (2001-10-01), Thomas et al.
patent: 6368854 (2002-04-01), Weiss et al.
patent: 6497872 (2002-12-01), Weiss
patent: 6638501 (2003-10-01), Bjornson
patent: 6670397 (2003-12-01), Baranowitz
patent: 6787355 (2004-09-01), Miller et al.
patent: 6808702 (2004-10-01), Pasricha
patent: 6824973 (2004-11-01), Tang
patent: 6833268 (2004-12-01), Green
patent: 2001/0038836 (2001-11-01), During et al.
patent: 2002/0142457 (2002-10-01), Umezawa et al.
patent: 2002/0146821 (2002-10-01), Sanchez-Ramos et al.
patent: 2002/0168350 (2002-11-01), Brazelton et al.
patent: 2002/0168765 (2002-11-01), Prockop et al.
patent: 2003/0053992 (2003-03-01), Rader
patent: 2003/0059868 (2003-03-01), Greenwood et al.
patent: 2003/0118566 (2003-06-01), Neuman
patent: 2003/0139410 (2003-07-01), Sugaya
patent: 2003/0148513 (2003-08-01), Sugaya et al.
patent: 2003/0219898 (2003-11-01), Sugaya
patent: 2004/0034049 (2004-02-01), Okawa
patent: 2004/0103448 (2004-05-01), Bjorklund
patent: 2004/0106197 (2004-06-01), Okano et al.
patent: 2005/0169897 (2005-08-01), Snyder
patent: 2005/0181503 (2005-08-01), Goldman
patent: 0 192 783 (1986-09-01), None
patent: 0 305 184 (1989-03-01), None
patent: 0 612 746 (1994-08-01), None
patent: 0 648 495 (1995-04-01), None
patent: 64-040483 (1989-02-01), None
patent: 64-079183 (1989-03-01), None
patent: 1-139572 (1989-06-01), None
patent: 7-90002 (1995-04-01), None
patent: 8-502172 (1996-03-01), None
patent: 8-325268 (1996-12-01), None
patent: 9-507747 (1997-08-01), None
patent: 9-295946 (1997-11-01), None
patent: 9-328435 (1997-12-01), None
patent: 10-504308 (1998-04-01), None
patent: 2001-504123 (2001-03-01), None
patent: 2001-526884 (2001-12-01), None
patent: 2002-500624 (2002-01-01), None
patent: 2002-502858 (2002-01-01), None
patent: 2002-518990 (2002-07-01), None
patent: WO 87/04928 (1987-08-01), None
patent: WO 89/01938 (1989-03-01), None
patent: WO 93/01275 (1993-01-01), None
patent: WO 94/09119 (1994-04-01), None
patent: WO 94/10292 (1994-05-01), None
patent: WO 94/16718 (1994-08-01), None
patent: WO 95/13364 (1995-05-01), None
patent: WO 96/04789 (1996-02-01), None
patent: WO96/15226 (1996-05-01), None
patent: WO 96/15226 (1996-05-01), None
patent: WO 98/22127 (1998-05-01), None
patent: WO 98/32457 (1998-07-01), None
patent: WO 99/11758 (1999-03-01), None
patent: WO 99/32606 (1999-07-01), None
patent: WO 99/40107 (1999-08-01), None
patent: WO 99/43286 (1999-09-01), None
patent: WO00/29550 (2000-05-01), None
patent: WO 03/60085 (2000-05-01), None
patent: WO 00/69448 (2000-11-01), None
patent: WO 01/11011 (2001-02-01), None
patent: WO 01/34167 (2001-05-01), None
patent: WO 01/53461 (2001-07-01), None
patent: WO 01/59072 (2001-08-01), None
patent: WO 02/064748 (2002-08-01), None
patent: WO03/060085 (2003-07-01), None
patent: WO 03/060085 (2003-07-01), None
patent: 2005/009359 (2005-02-01), None
Coleman et al., Developmental Biology (1969), 19(6): 527-548 Abstract, Caplus Accession No. 1969:420164.
Kidson et al., Experimental Cell Research, vol. 188, Issue 1, May 1990, pp. 36-41, Abstract.
Alvarez-Buylla et al., 1997,J. Neurobiology33: 585-601.
Benninger et al., 2000,Brain Pathol. 10: 330-341.
Blakemore et al., 1991,Trends Neurosci. 14: 323-327.
Blakemore et al., 2000,Cell Transplant. 9: 289-294.
Brannen et al., 2000,Neuroreport11: 1123-8.
Carpenter et al., 1999,Experimental Neurology158: 265-278.
Cattaneo et al., 1996,Mol. Brain Res. 42: 161-66.
Doetsch et al., 1999,Cell97: 703-16.
Eckenstein et al., 1994,Biochem. Pharmacol. 47: 103-110.
Fricker et al., 1999,J. Neurosci. 19: 5990-6005.
Frölichsthal-Schoeller et al., 1999,NeuroReport10: 345-351.
Gonzalez et al., 1995,Brain Res. 701: 201-226.
Gould et al., 1999,Science286: 548-552.
Hatton et al., 1992,Glia5: 251-258.
Johansson et al., 1999,Cell96: 25-34.
Kurimoto et al., 2001, Neurosci Let. 306: 57-60.
Lundberg et al., 1996,Exp. Neurol. 139: 39-53.
Nishida et al., 2000, Invest Ophthalmol Vis Sci 41: 4268-74.
Pundt et al., 1995,Brain Res. 695: 25-36.
Qu et al., 2001, Neuroreport 12: 1127-32.
Rosser et al., 2000,Eur. J. Neurosci. 12: 2405-2413.
Rubio et al., 2000,Mol. Cell. Neurosci. 16: 1-13.
Svendsen et al., 1998,J. Neurosci. Methods85: 141-152.
Svendsen et al., 1999,Brain Pathol. 9: 499-51.
Warfvinge et al., 2001, Exp. Neurol. 169: 1-12.
Williams et al., 1996,J. Comp. Neurol. 370: 147-158.
Daadi et al Generation of tyrosine hydroxylase-producing neurons from precursors of the embryonic and adult forebrain. The Journal of Neuroscience. Jun. 1, 1999, vol. 19, No. 11, pp. 4484-4497.
Murphy et al. Neural Stem Cells. Journal of Investigative Dermatology Symposium Proceedings. Aug. 1997, vol. 2, No. 1, pp. 8-13.
Mazurova et al. New therapeutic approaches for the treatment of Huntington's disease. Acta Medica 2001, vol. 44, No. 4 pp. 119-123.
Memberg et al. Proliferation, differentiation and survival of rat sensory neuron precursors in vitro require specific trophic factors. Molecular and Cellular Neuroscience. Aug. 1995, vol. 6, No. 4, pp. 323-335.
Andrews et al. TNFa potentiates IFN g-induced cell death in oligodendrocyte progenitors. Journal of Neuroscience Research. Dec. 1998, vol. 54, No. 5, pp. 574-583.
Brewer. Regeneration and proliferation of embryonic and adult rat hippocampal neurons in culture. Experimental Neurology. Sep. 1999, vol. 159, No. 1, pp. 237-247.
International Preliminary Examination Report of Nov. 5, 2003 for PCT/US03/01254.
International Preliminary Examination Report of Dec. 23, 2003 for PCT/US03/01014.
International Preliminary Examination Report of Dec. 31, 2003 for PCT/US03/01258.
Pagan, R. et al. Epithelial-mesenchymal transition of cultured rat neonatal hepatocytes is differentially regulated in response to epidermal growth factor and dimethyl sulfoxide. 1997, Hepatology, vol. 25, No. 3, pp. 598-606.
Cheng, C. et al. In vivo proliferation, migration and phenotypic changes of Schwann cells in the presence of myelinated fibers. Neuroscience. Nov. 2002, vol. 115, No. 1, pp. 321-329.
Bayarshaihan, D. et al. Rapid identification of novel chondrocyte-specific gene by RNA differential display. Biochem. And Biophys. Res. Comm. 1995, vol. 220, pp. 449-452.
Sanjo et al. A novel neutrophic pyrimidine compound MS-818 enhances neurotrophic effects of basic fibriblast growth factor. Journal of Neuroscience Research, 1998, vol. 54, pp. 604-612.
Burt et al. Treatment of autoimmune disease by Intense immunosuppressive conditioning and autologous hematopoietic stem cell transplantation. Blood, 1998, vol. 92, No. 10, pp. 3505-3514.
Fukuyama et al., “A synthesized pyrimidine compound, MS-818, promotes walking function recovery from crush injury of the sciatic nerve through its indirect stimulation of Schwann cells”Restorative Neurology and Neuroscience17 (2000) 9-16.
Yoshikawa et al., “The Effect of MS-818, Newly Synthesized Pyrimidine Compound, on Fracture Repair”Kobe J. Med. Sci. 46:265-282 (Dec. 2000).
Itoh et al., “The Effect of neurotrophic pyrimidine heterocy

Affiliated with

Also associated with

Rating

Mammalian multipotent neural stem cells and compositions,... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Mammalian multipotent neural stem cells and compositions,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mammalian multipotent neural stem cells and compositions,... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4135710